- Advertisement -

Nanoparticles in Biotechnology and Pharmaceuticals Market Size, Scope And Forecast | Top Key Company Profiles – Roche, GE Healthcare, Merck, Novartis, AMAG Pharmaceuticals, Amgen...

New Jersey, United States,- This Nanoparticles in Biotechnology and Pharmaceuticals Market report divides the market into segments and sub-segments. With this market analysis, managing the breakdown...

Insilico Medicine’s pan-TEAD inhibitor ISM6331 receives FDA IND clearance for mesothelioma treatment

Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced ISM6331, potential best-in-class pan-TEAD inhibitor, has received the U.S. Food and...

Pan-cancer analysis uncovers a new class of promising CAR T–cell immunotherapy targets

(MEMPHIS, Tenn. – May 03, 2024) Targeting anti-cancer therapy to affect cancer cells but not healthy cells is challenging. For chimeric antigen receptor (CAR)...

Researchers develop $1 cancer treatment using engineered bacteria

What if a single one-dollar dose could cure cancer? A multi-university team of researchers, supported by federal funding, is developing a highly efficient bacterial...

U.K. Starts Oxford Coronavirus Vaccine Trial as Germany Green-Lights BioNTech and...

The first human trials of a coronavirus vaccine developed by researchers at the University of Oxford will start today in the U.K. Making the...

Advancing CAR T-cell therapy for treatment of solid tumors

Reviewed by Emily Henderson, B.Sc.Mar 25 2020 The full title of the research is "The study of the mechanisms of effectiveness of T-cells CAR-T towards...

Pharma Races to Scale AI as Billions Flow into Drug Discovery

“I’ve always believed the No.1 application of AI should be to improve human health.”  –Demis Hassabis, PhD, CEO of Google DeepMind and Isomorphic Labs, 2024...

ASMS 2026: Solving Proteomics’ Next Bottleneck

At the 74th American Society for Mass Spectrometry (ASMS) Conference in San Diego, the obvious story was hardware. Vendors showcased faster acquisition, higher sensitivity,...

Pharma Races to Scale AI as Billions Flow into Drug Discovery

“I’ve always believed the No.1 application of AI should be to improve human health.”  –Demis Hassabis, PhD, CEO of Google DeepMind and Isomorphic Labs, 2024...

ASMS 2026: Solving Proteomics’ Next Bottleneck

At the 74th American Society for Mass Spectrometry (ASMS) Conference in San Diego, the obvious story was hardware. Vendors showcased faster acquisition, higher sensitivity,...

Peptistar Began Operation of the Asahi Kasei FO-MD System at Manufacturing Scale

Japanese CDMO Peptistar reports that it has integrated Asahi Kasei’s forward osmosis–membrane distillation (FO–MD) system into its facility for trial production of active pharmaceutical...

more new items

Pharma Races to Scale AI as Billions Flow into Drug Discovery

“I’ve always believed the No.1 application of AI should be to improve human health.”  –Demis Hassabis, PhD, CEO of Google DeepMind and Isomorphic Labs, 2024...

ASMS 2026: Solving Proteomics’ Next Bottleneck

At the 74th American Society for Mass Spectrometry (ASMS) Conference in San Diego, the obvious story was hardware. Vendors showcased faster acquisition, higher sensitivity,...

Peptistar Began Operation of the Asahi Kasei FO-MD System at Manufacturing...

Japanese CDMO Peptistar reports that it has integrated Asahi Kasei’s forward osmosis–membrane distillation (FO–MD) system into its facility for trial production of active pharmaceutical...